WeVote
Log In

Bill

Bill

SR 113

A resolution to designate May 2026 as Amyotrophic Lateral Sclerosis (ALS) Month.

2025-2026 Regular Session Introduced by Mary Cavanagh and 5 co-sponsors

Designates May 2026 as ALS Month in Michigan to raise awareness and promote advocacy, research, and support for ALS care and services.

ADOPTED
0
WeVote Research Nonpartisan
Bill Summary · SR 113

Summary: Senate Resolution No. 113 (SR-113) – Designate May 2026 as Amyotrophic Lateral Sclerosis (ALS) Month

Overview

  • Jurisdiction: Michigan
  • Session: 2025-2026
  • Type: Senate Resolution (non-binding)
  • Introduced by: Senator Roger Hauck
  • Co-sponsors: Senators Stephanie Chang, Mary Cavanagh, Jeremy Moss, Erika Geiss, Dayna Polehanki
  • Status: Adopted by the Senate on April 22, 2026 (rules suspended and adopted on the same day)

Purpose and Intent

The resolution designates May 2026 as ALS Month in Michigan. It aims to raise public awareness of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, and to highlight the importance of research, funding, and support services for individuals and families affected by ALS in Michigan.

Key Provisions

  • Designation: The month of May 2026 is proclaimed as ALS Month by the Michigan Senate.
  • Purpose of designation:
    • Increase public awareness of ALS and its impact.
    • Emphasize the need for ongoing research to identify causes and a potential cure.
    • Support the expansion of services and resources for people with ALS and their families.
    • Encourage funding and advocacy to improve care, extend lives, and reduce the burden of the disease.

What Would Be Affected

  • Audience and Focus: Residents of Michigan, policymakers, healthcare providers, researchers, patient organizations, and families affected by ALS.
  • Activities and Impacts: The designation may inspire awareness activities, educational campaigns, fundraising efforts, and engagement with ALS-related organizations during May 2026. It does not enact funding, create new programs, or revise statutes, but signals legislative support for ALS awareness and related initiatives.

Procedural and Timeline Aspects

  • Effective Date of Designation: May 2026 (specific date range not required beyond the month itself)
  • Legislative Action: The resolution was introduced and promptly advanced—rules suspended and the resolution adopted on April 22, 2026.

Contextual Notes

  • ALS is a progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord, leading to loss of voluntary muscle movement.
  • The resolution cites statistics to underscore the disease burden (approximately 30,000 Americans with ALS at any time in the U.S., around 5,000 new cases annually, about 15 new cases diagnosed each day, and a death roughly every 90 minutes in the U.S.).
  • The language emphasizes awareness, early symptom management through treatment of symptoms, and public engagement as avenues toward better outcomes and funding for ALS research and support.

Bottom Line

SR-113 is a ceremonial, non-binding resolution that designates May 2026 as ALS Month in Michigan to promote awareness, understanding, and advocacy for ALS research, care, and support services. It reflects bipartisan and cross-ideological support for addressing the impact of ALS on individuals and families within the state.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.